| 注册
首页|期刊导航|中国药房|细菌溶解产物胶囊防治儿童反复呼吸道感染有效性和安全性的Meta分析

细菌溶解产物胶囊防治儿童反复呼吸道感染有效性和安全性的Meta分析

戎萍 马融 张喜莲 闫海虹

中国药房2018,Vol.29Issue(12):1702-1706,5.
中国药房2018,Vol.29Issue(12):1702-1706,5.DOI:10.6039/j.issn.1001-0408.2018.12.27

细菌溶解产物胶囊防治儿童反复呼吸道感染有效性和安全性的Meta分析

Efficacy and Safety of Bacterial Lysates for Recurrent Respiratory Infection of Children:A Meta-analysis

戎萍 1马融 1张喜莲 1闫海虹2

作者信息

  • 1. 天津中医药大学第一附属医院儿科,天津 300381
  • 2. 天津中医药大学研究生院,天津 300193
  • 折叠

摘要

Abstract

OBJECTIVE:To evaluate the efficacy and safety of Bacterial lysates(hereinafter referred to as"Broncho-Vaxom") for recurrent respiratory tract infections (RRTIs) of children,and to provide evidence-based reference for clinic. METHODS:Retrieved from PubMed,EMBase,Cochrane Library,CBM,CNKI,Wanfang database and VIP database,domestic and foreign published randomized controlled trials (RCTs) about Broncho-Vaxom (trail group) vs. placebo (control group) for RRTIs of children were collected during database establishment to Jan. 2018. After literature scanning and data extraction,the risk of bias of included trials were evaluated by using Cochrane 5.1.0 risk bias evaluation tool. Meta-analysis was performed by using Rev Man 5.3 software. RESULTS:A total of 13 RCTs involving 1 228 children were included. The results showed that the trial group was superior to control group in frequency of respiratory infection [MD=-1.14,95%CI(-1.29,-0.99),P<0.001],total response rate [RR=9.47,95%CI(2.33,38.54),P=0.002],the time of antibiotics use [MD=-4.36,95%CI(-6.52,-2.21),P<0.001], infection duration [MD=-3.89,95%CI(-4.47,-3.04),P<0.001],febrile time [MD=-1.81,95%CI(-3.40,-0.22),P=0.03],serum immunoglobulin (Ig)G level [MD=1.25,95%CI(0.13,2.37)),P=0.03],IgA level [MD=0.77,95%CI(0.07, 1.46),P=0.03] and the level of T cell subgroup CD4+[MD=1.33,95%CI(0.90,1.76),P<0.001] and CD8+[MD=0.64,95%CI (0.24,1.04),P=0.002],there was statistical significance. Trail group was similar to control group in respect of cough time [MD=-6.00,95%CI(-13.86,1.86),P=0.13] and IgM level [MD=-0.10,95%CI(-0.32,0.12),P=0.39] and the incidence of ADR [RR=0.76,95%CI(0.43,1.35),P=0.35]. CONCLUSIONS:The current evidence shows that Broncho-Vaxom could effectively prevent the RRTIs of children with good safety.

关键词

泛福舒/细菌溶解产物胶囊/儿童/反复呼吸道感染/安慰剂/有效性/安全性/Meta分析

Key words

Broncho-Vaxom/Bacterial lysates/Children/Recurrent respiratory tract infection/Placebo/Efficacy/Safe-ty/Meta-analysis

分类

医药卫生

引用本文复制引用

戎萍,马融,张喜莲,闫海虹..细菌溶解产物胶囊防治儿童反复呼吸道感染有效性和安全性的Meta分析[J].中国药房,2018,29(12):1702-1706,5.

基金项目

国家自然科学基金资助项目(No.81503612) (No.81503612)

国家中医药管理局中医药标准化项目(No.国中医药法监函〔2015〕192号) (No.国中医药法监函〔2015〕192号)

中国药房

OA北大核心CSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文